Delhi hospital sets global benchmark in Tomotherapy

Written By dna Correspondent | Updated: Dec 14, 2018, 06:20 AM IST

Picture for representation

The audit is conjointly conducted by World Health Organisation and the International Atomic Energy Agency (IAEA) to optimise dose delivery in radiation therapy.

A Delhi based hospital has set international benchmark for Cyberknife and Tomotherapy in the country by meeting the exact international metrics of Postal Dosimetry Audit for CyberKnife and Tomotherapy. 

The audit is conjointly conducted by World Health Organisation and the International Atomic Energy Agency (IAEA) to optimise dose delivery in radiation therapy.

CyberKnife is a non-invasive option for patients who have inoperable or surgically complex tumors, or who may be looking for an alternative to surgery. The CyberKnife system enables our radiation oncologists to deliver targeted, high doses of radiation to a broad range of tumors throughout the body whereas, Tomography is imaging by sections or sectioning, through the use of any kind of penetrating wave. The method is used in radiology.

"I congratulate the team for passing the world-renowned Postal Dosimetry Audit and becoming the first organisation in India to receive this certification. Exercises such as this re-enforce our credo of delivering excellent radiation therapy treatment for all our patients. With the incidence of cancer cases rising exponentially, Radiation Oncology will play a crucial role in managing and curing cancer. Specialised treatment options such as CyberKnife and Tomotherapy that are non-invasive provide greater accuracy and minimise patient discomfort," said Dr.Naresh Trehan, Chairman and Managing Director, Medanta.

IAEA has provided Postal Audit of Radiation Beam Dosimetry since 1969 to standardise treatment delivery. Medanta Cancer Institute was among 15 centres worldwide to participate in the audit. It has successfully conducted 1,340 CyberKnife therapies and 780 Tomotherapy treatments till date.

'We are proud to have cleared this internationally benchmarked quality assurance audit and hope to deliver radiation therapies of global standards to patients. We look forward to serving both national and international patients who need superlative care through world-class treatment under a single roof," said Dr Tejinder Kataria, Chairperson, Radiation Oncology, Medanta Cancer Institute.

ACCURACY RATE

  • With the incidence of cancer cases rising exponentially, Radiation Oncology will play a crucial role in managing and curing cancer
     
  • Specialised treatment options such as CyberKnife and Tomotherapy that are non-invasive provide greater accuracy